Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00315_DB00998> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00315_DB00998 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00998 label "DDI between Zolmitriptan and Frovatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and frovatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00998]" assertion.
- drugbank_resource:DB00315_DB00998 identifier "drugbank_resource:DB00315_DB00998" assertion.
- drugbank_resource:DB00315_DB00998 title "DDI between Zolmitriptan and Frovatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and frovatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.